Rising stars
Aprea Therapeutics
Aprea Therapeutics AB is working on the development of a new p53-based treatment for cancer. Klas Wiman is one of the company’s founders, and he draws a clear distinction between the roles of researcher and entrepreneur.
Cellaviva/Nextcell Pharma
Biobank Cellaviva offers parents-to-be the chance to store stem cells from umbilical cord blood and tissue at birth. Experiences from stem cell management have now led to the development of one of Sweden’s first cell therapy drug treatments.
Modus Therapeutics
Many years’ research has led Mats Wahlgren to a possible first drug treatment for acute manifestations of sickle cell anemia - a genetic condition that affects millions of people.
Oncopeptides
Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.
BioArctic
BioArctic is getting closer to producing a drug that substantially limits the development of Alzheimer’s.
Heartrunner Sweden
In Sweden, there are currently some 21,000 volunteers ready to respond to help cardiac arrest victims. A smartphone alert system guides them directly to victims – often faster than ambulances. The service, the result of research carried out at the Centrum för Hjärtstoppsforskning, is now ready for export markets.
